Latest Breaking News On - Peterl hoang - Page 1 : comparemela.com

Marker Therapeutics (MRKR) and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

Marker Therapeutics (MRKR) and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lincoln parkUnited statesPeterl hoangLincoln park capital fundExchange commissionMarker therapeutics incCommon stock purchase agreementPurchase agreementCurrent report

Marker Therapeutics Shares Double After Hours, FDA Approves IND for MT-601

Marker Therapeutics Shares Double After Hours, FDA Approves IND for MT-601
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Stephen nakrosisPeterl hoangMarker therapeutics incDow jones company incDrug administrationMarker therapeuticsDow jones

Marker Therapeutics (MRKR) Announces FDA Clearance of IND for MT-601

Marker Therapeutics (MRKR) Announces FDA Clearance of IND for MT-601
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mythili koneruPeterl hoangCompany investigational new drugMarker therapeutics incDrug administrationInvestigational new drugChief medicalChief executiveCompany sponsored phase

Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma

Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNeda safarzadehviceMythili koneruMediaamy bonannoPeterl hoangMarker therapeutics incCompany investigational new drugDrug administrationInvestigational new drugChief medicalChief executiveCompany sponsored phaseMarker therapeuticsInc marker therapeuticsLooking statements thisPrivate securities litigation reform act

Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results

17.03.2022 - Enrollment of first 20 patients of the Company’s Phase 2 acute myeloid leukemia (AML) trial completed in Q4 2021 Topline readout of Group 2 active disease anticipated in Q2 2022 Company plans to file INDs in lymphoma and pancreatic cancer by year .

United statesNeda safarzadehPeterl hoangKatharine knobilCompany board of directorsMarker therapeutics incDrug administrationChief executiveMyeloid leukemiaCompany sponsored phaseInvestigational new drugClinical programsOrphan drugMarker therapeuticsPrivate securities litigation reform actConsolidated statements